Brainstorm Cell Therapeutics (BCLI)
OTHER OTC:BCLI
Want to see BCLI full AI Analyst Report?
Technical Sentiment
Overall Consensus
Strong Sell
2Bullish
6Neutral
14Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Brainstorm Cell Therapeutics’s (BCLI) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Brainstorm Cell Therapeutics is a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 20-Day exponential moving average is 0.71, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 50-Day exponential moving average is 0.74, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Sell.
Brainstorm Cell Therapeutics (BCLI) Pivot Points
Classic
0.51
0.60
0.65
0.74
0.79
0.88
0.93
Fibonacci
0.60
0.65
0.68
0.74
0.79
0.82
0.88
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Brainstorm Cell Therapeutics (BCLI) Moving Averages
MA5
0.70Sell
0.70Sell
MA10
0.69Sell
0.70Sell
MA20
0.68Sell
0.71Sell
MA50
0.79Sell
0.74Sell
MA100
0.70Sell
0.73Sell
MA200
0.68Sell
0.76Sell
Brainstorm Cell Therapeutics’s (BCLI) 10-Day exponential moving average is 0.70, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 100-Day exponential moving average is 0.73, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Sell.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.57 and Brainstorm Cell Therapeutics’s (BCLI) 50-day simple moving average is 0.79, creating a Sell signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.57 and Brainstorm Cell Therapeutics’s (BCLI) 100-day simple moving average is 0.70, creating a Sell signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.57 and Brainstorm Cell Therapeutics’s (BCLI) 200-day simple moving average is 0.68, creating a Sell signal.
Brainstorm Cell Therapeutics (BCLI) Technical Indicators
RSI (14)
41.51
Neutral
STOCH (9,6)
43.15
Neutral
STOCHRSI (14)
55.30
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
32.63
Neutral
Williams %R
-70.00
Buy
CCI (14)
1.34
Neutral
ATR (14)
0.05
-
Ultimate Oscillator
34.63
Neutral
ROC
4.62
Buy
Brainstorm Cell Therapeutics’s (BCLI) Relative Strength Index (RSI) is 41.51, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Trend Strength Indicator (ADX) is 32.63, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Commodity Channel Index (CCI) is 1.34, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Price Rate of Change (ROC) is 4.62, creating a Buy signal.
FAQ
Is BCLI a Buy, Hold, or Sell?
Based on BCLI’s technical indicators, BCLI is a Strong Sell.
What is BCLI’s RSI (14)?
BCLI’s RSI (14) is 41.51, which suggests BCLI is a Neutral.
What is BCLI’s MACD?
BCLI’s MACD is -0.02, which suggests BCLI is a Sell.
What is BCLI’s 5-day moving average?
BCLI’s 5-day moving average is 0.70, which suggests BCLI is a Sell.
What is BCLI’s 20-day moving average?
BCLI 20-day moving average is 0.68, which suggests BCLI is a Sell.
What is BCLI’s 50-day moving average?
BCLI’s 50-day moving average is 0.79, which suggests BCLI is a Sell.
What is BCLI’s 200-day moving average?
BCLI’s 200-day moving average is 0.68, which suggests BCLI is a Sell.
What is BCLI’s Williams % R (14)?
BCLI’s Williams % R (14) is -70.00, which suggests BCLI is a Buy.
What is BCLI’s CCI (14)?
BCLI’s CCI (14) is 1.34, which suggests BCLI is a Neutral.